Advertisement
Australia markets closed
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • AUD/USD

    0.6614
    -0.0008 (-0.12%)
     
  • OIL

    79.76
    +0.50 (+0.63%)
     
  • GOLD

    2,374.10
    +33.80 (+1.44%)
     
  • Bitcoin AUD

    95,624.48
    +2,630.62 (+2.83%)
     
  • CMC Crypto 200

    1,355.56
    -2.45 (-0.18%)
     
  • AUD/EUR

    0.6133
    -0.0005 (-0.08%)
     
  • AUD/NZD

    1.0986
    +0.0017 (+0.16%)
     
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NASDAQ

    18,113.46
    +28.46 (+0.16%)
     
  • FTSE

    8,421.17
    +39.82 (+0.48%)
     
  • Dow Jones

    39,387.76
    +331.36 (+0.85%)
     
  • DAX

    18,750.70
    +64.10 (+0.34%)
     
  • Hang Seng

    18,963.63
    +425.82 (+2.30%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?

After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?

Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position.